Recombinant Human Endostatin Adenovirus Combined With Chemotherapy for Advanced Head and Neck Malignant Tumors

Clinical trial NCT02283489 · UNKNOWN

Trial details

NCT number: NCT02283489
Sponsor: Renmiao Zhang
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Neoplasms

Start date: 2014-10-01
Primary completion: 2016-10-01
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.